Clinical Trials Browser

OTHER × Leukemia, Myeloid, Chronic-Phase × Tyrosine Kinase Inhibitors × Clear all

NCT06121765 2023-11-08

Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT04006847 2022-07-01

Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Phase 1/2 Terminated

1 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase